Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
124,1 DKK | +0,16% | -2,90% | +22,63% |
14/03 | Transcript : ALK-Abelló A/S - Shareholder/Analyst Call | |
05/03 | Nieuwe aankopen voor de Europese portefeuille |
Vakgebied
Aantal werknemers: 2 824
Verkoop per activiteit
DKK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Sublingual Immunotherapy-Tablets
47,6
%
| 2 102 | 46,6 % | 2 296 | 47,6 % | +9,23% |
Subcutaneous Immunotherapy/Sublingual Immunotherapy-Drops
40,2
%
| 1 748 | 38,7 % | 1 939 | 40,2 % | +10,93% |
Other
12,2
%
| 661 | 14,7 % | 589 | 12,2 % | -10,89% |
Verkoop per regio
DKK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Europe
38,5
%
| 2 939 | 65,2 % | 1 858 | 38,5 % | -36,79% |
North America
15,8
%
| 857 | 19,0 % | 763 | 15,8 % | -11,00% |
Germany
14,7
%
| - | - | 708 | 14,7 % | - |
International
13,1
%
| 596 | 13,2 % | 630 | 13,1 % | +5,70% |
France
11,3
%
| - | - | 547 | 11,3 % | - |
United States
3,0
%
| - | - | 145 | 3,0 % | - |
Denmark
2,2
%
| 119 | 2,6 % | 104 | 2,2 % | -12,61% |
Japan
1,5
%
| - | - | 70 | 1,5 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Peter Halling
CEO | Chief Executive Officer | 45 | 01/01 |
Director of Finance/CFO | 52 | 01-06-23 | |
Chief Tech/Sci/R&D Officer | - | 01-03-23 | |
Director/Board Member | 48 | - | |
Director/Board Member | 55 | - | |
Lisbeth Kirk
IRO | Public Communications Contact | - | 01-10-19 |
Per Plotnikof
IRC | Investor Relations Contact | - | - |
Corporate Officer/Principal | - | 01-05-94 | |
Corporate Officer/Principal | 53 | 01-06-12 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 57 | 18-03-21 | |
Anders Hedegaard
CHM | Chairman | 63 | 11-03-20 |
Director/Board Member | 64 | 12-03-15 | |
Director/Board Member | 64 | 01-01-14 | |
Bertil Lindmark
BRD | Director/Board Member | 68 | 18-03-21 |
Director/Board Member | 55 | - | |
Alan Main
BRD | Director/Board Member | 61 | 16-03-22 |
Director/Board Member | 48 | - | |
Johan Smedsrud
BRD | Director/Board Member | 52 | 01-01-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 10 | 1 841 520 | 0 | 0 | 58,99 % |
Aandeel B | 10 | 18 415 200 | 0 | 0 | |
Aandeel C | 1 | 202 567 200 | 131 435 987 ( 64,89 %) | 1 634 673 ( 0,8070 %) |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
ALK-ABELLÓ A/S 0.81% | 1 634 673 | 0.81% | 30 494 531 $ |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+22,63% | 3,98 mld. | |
+33,77% | 701 mld. | |
+26,24% | 571 mld. | |
+0,99% | 381 mld. | |
+21,09% | 334 mld. | |
+17,47% | 319 mld. | |
+0,74% | 210 mld. | |
+2,95% | 210 mld. | |
-6,05% | 201 mld. | |
-3,51% | 157 mld. |
- Beurs
- Aandelen
- Aandeel ALK-Abelló A/S - Nasdaq Copenhagen
- Onderneming ALK-Abelló A/S